Patient/Population | Infant < 37 weeks completed gestational age |
Intervention | ≥1 dose of furosemide (IV or PO) during hospitalization in the neonatal intensive care unit |
Control | Infant < 37 weeks completed gestational age without exposure to furosemide |
Outcomes | sensorineural hearing loss; nephrocalcinosis/nephrolithiasis |
Study Design | clinical trials, retrospective or prospective cohort studies, case-control studies |